iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

Nuclera has extended its Series C funding to a total [...]

Bio‑Sourcing and Zerion Pharma have joined forces to develop the [...]

FairJourney Bio (FJBio) has expanded its portfolio with the launch [...]

Argobio Studio has announced the successful seed financing of Enodia [...]

TECregen, a biotechnology company focused on thymus regeneration, has completed [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

Grifols has received US Food and Drug Administration (FDA) approval [...]